1/9/2007 11:55:41 AM
BOULDER, Colo.--(BUSINESS WIRE)--BaroFold, Inc. announced today the granting of a multi-site research license to Pfizer, Inc. (NYSE: PFE) for BaroFold’s proprietary PreEMT™ high pressure technology for solubilizing, disaggregating and refolding proteins. Financial terms were not disclosed. Pfizer joins several other biotechnology firms and pharmaceutical corporations who have licensed BaroFold’s technology to refold and produce proteins.
comments powered by